Viehbacher Christopher bought BIIB
February 7, 2024 · Form 4 insider transaction
Viehbacher Christopher bought 27,025 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,025
Price
$0.00
Total value
N/A
InsiderViehbacher Christopher
Role—
CompanyBiogen Inc. (BIIB)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2024
Filing dateFebruary 9, 2024
Shares owned after27,025
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.